NO853249L - Pellet-preparat. - Google Patents

Pellet-preparat.

Info

Publication number
NO853249L
NO853249L NO853249A NO853249A NO853249L NO 853249 L NO853249 L NO 853249L NO 853249 A NO853249 A NO 853249A NO 853249 A NO853249 A NO 853249A NO 853249 L NO853249 L NO 853249L
Authority
NO
Norway
Prior art keywords
pellet
active substance
weight
gastric juice
pellet preparation
Prior art date
Application number
NO853249A
Other languages
English (en)
Norwegian (no)
Inventor
Hans-Dieter Dell
Reinhold Kraus
Detlef Schierstedt
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of NO853249L publication Critical patent/NO853249L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO853249A 1984-08-30 1985-08-16 Pellet-preparat. NO853249L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431861 DE3431861A1 (de) 1984-08-30 1984-08-30 Pellet-zubereitung

Publications (1)

Publication Number Publication Date
NO853249L true NO853249L (no) 1986-03-03

Family

ID=6244255

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853249A NO853249L (no) 1984-08-30 1985-08-16 Pellet-preparat.

Country Status (16)

Country Link
US (1) US4900557A (enExample)
EP (1) EP0173210B1 (enExample)
JP (1) JPH0759501B2 (enExample)
KR (1) KR860001591A (enExample)
AT (1) ATE52688T1 (enExample)
AU (1) AU4657085A (enExample)
CA (1) CA1255223A (enExample)
DE (2) DE3431861A1 (enExample)
DK (1) DK163208C (enExample)
FI (1) FI853296L (enExample)
GR (1) GR852101B (enExample)
HU (1) HUT39607A (enExample)
IL (1) IL76201A0 (enExample)
NO (1) NO853249L (enExample)
PT (1) PT81039B (enExample)
ZA (1) ZA856597B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2196252B (en) * 1986-09-18 1990-10-17 London Pharmacy Innovation Gastric controlled-release dosage forms
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
JPH06508371A (ja) 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
DE69305313T3 (de) * 1992-12-22 2001-06-21 The University Of Cincinnati, Cincinnati Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
CA2383212C (en) 1999-09-02 2008-11-25 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
TR200300731T2 (tr) 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
EP2112920B1 (en) * 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
CN100336501C (zh) * 2003-08-06 2007-09-12 健乔信元医药生技股份有限公司 醋炎痛缓释性圆粒组成物及制备方法
US20070224269A1 (en) * 2004-06-10 2007-09-27 Rubino Orapin P Controlled Release Pharmaceutical Formulation
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
BRPI0611342A2 (pt) 2005-04-29 2010-08-31 Tendix Dev Llc motor de combustão interna
BRPI0614197B8 (pt) * 2005-08-02 2021-05-25 Drossapharm Ag composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
EP3764983B1 (en) 2018-04-13 2021-09-01 Santa Farma Ilaç Sanayi A.S. A sustained release formulation comprising acemetacin with bimodal in vitro release
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
WO2019223753A1 (zh) 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法
WO2020101584A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Sustained release acemetacin compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801203A (en) * 1951-03-22 1957-07-30 Byk Gulden Lomberg Chem Fab X-ray method of digestive enzyme diagnosis using protected core of contrast agent
NO98024A (enExample) * 1956-11-05
US3017329A (en) * 1957-08-15 1962-01-16 Dow Chemical Co Method of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
US3065142A (en) * 1958-07-30 1962-11-20 Armour Pharma Gastric resistant medicinal preparation
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
JPS54138128A (en) * 1978-04-19 1979-10-26 Akiyama Jiyouzai Kk Double contrast medium for intestine
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH04225410A (ja) * 1990-12-27 1992-08-14 Hitachi Ltd 文書編集装置

Also Published As

Publication number Publication date
FI853296A7 (fi) 1986-03-01
US4900557A (en) 1990-02-13
DK163208C (da) 1992-06-29
ZA856597B (en) 1986-04-30
PT81039A (en) 1985-09-01
HUT39607A (en) 1986-10-29
EP0173210B1 (de) 1990-05-16
FI853296A0 (fi) 1985-08-28
DE3577654D1 (de) 1990-06-21
EP0173210A2 (de) 1986-03-05
DK163208B (da) 1992-02-10
JPS6165817A (ja) 1986-04-04
DK394685A (da) 1986-03-01
CA1255223A (en) 1989-06-06
AU4657085A (en) 1986-03-06
JPH0759501B2 (ja) 1995-06-28
KR860001591A (ko) 1986-03-20
EP0173210A3 (en) 1987-05-13
IL76201A0 (en) 1985-12-31
FI853296L (fi) 1986-03-01
DE3431861A1 (de) 1986-03-13
ATE52688T1 (de) 1990-06-15
GR852101B (enExample) 1986-01-02
PT81039B (pt) 1987-12-30
DK394685D0 (da) 1985-08-29

Similar Documents

Publication Publication Date Title
NO853249L (no) Pellet-preparat.
Bodmeier Tableting of coated pellets
US4837031A (en) Compositions containing ibuprofen
US4728513A (en) Granular delayed-release form of pharmaceutically active substances
US5104648A (en) High ibuprofen content granulations
US5780055A (en) Cushioning beads and tablet comprising the same capable of forming a suspension
Saigal et al. Microcrystalline cellulose as a versatile excipient in drug research
JP2556623B2 (ja) 高いイブプロフェン含有量を示す顆粒状物
RS59672B1 (sr) Čvrsti dozni oblici palbocikliba
JPS60209518A (ja) 貯蔵安定性を有し急速に崩壊する薬学的に活性な物質を含有する圧縮成形体及びその製造方法
LT4844B (lt) Enterine danga padengta farmacinė tabletė ir jos pagaminimo būdas
WO2011077451A2 (en) Controlled release pharmaceutical composition
JPH07558B2 (ja) モピダモール製剤
CA2443632C (en) Timed pulse release composition
KR20000076475A (ko) 약제학적 활성 성분의 함량이 90중량% 이하인 펠렛의제조방법
NO157964B (no) Fremgangsmaate til fremstilling av hurtignedbrytbare legemiddel-presslegemer.
US20060088594A1 (en) Highly compressible controlled delivery compositions of metformin
KR100240362B1 (ko) 콜레스티폴 하이드로클로라이드의 정제화
RS66060B1 (sr) Sastav koji sadrži ramipril i indapamid
RU2451504C2 (ru) Способ получения мультичастиц с применением роликового компактора
RU2352338C2 (ru) Лекарственная композиция, содержащая флупиртин, с контролируемым высвобождением биологически активного вещества
HU221590B (hu) Béta-fenil-propiofenon-származékokat tartalmazó retard mikrotabletták
RS20060009A (sr) Oralni oblik za doziranje sakvinavir mezilata
Torrado et al. Tableting of multiparticulate modified release systems
HRP20040435A2 (en) Solid pharmaceutical formulation for a piperazineurea derivative